Lenzings, Writedowns

Lenzing's Writedowns and Its Alabama Bet Measure Two Different Things

Published on 11/21/2026 at 08:51 | Editorial boerse-global.de
Lenzing stock slid 15% over seven sessions; Berenberg trimmed its target to EUR 13.50 and kept Hold, as Heiligenkreuz sale review runs to end-2026.
Lenzing's Writedowns and Its Alabama Bet Measure Two Different Things Illustration mit AI erstellt.

Lenzing shares fell 5.9% on Friday to close at EUR 9.56, capping a week in which the stock shed 15% over seven straight sessions. The decline came as a selloff in international technology names stoked risk aversion across the Vienna market, where the ATX logged its seventh consecutive losing day, according to APA. Industrial stocks like Lenzing were caught in the drag.

The weekly slide coincided with two separate disclosures from the fiber maker. Late Thursday, Lenzing published a corrected voting rights notification showing the Goldman Sachs Group at a total position of 4.90% on the day the threshold was crossed, down from the 5.86% previously reported. Goldman Sachs Asset Management B.V. exercises voting rights over a 4.27% stake, while the legal owner of the shares, through subsidiaries, is NN Group N.V.

Berenberg Trims Target, Keeps Hold

Also on Thursday, Berenberg cut its price target to EUR 13.50 from EUR 17.00 while reaffirming its "Hold" rating. The broker's 2026 earnings-per-share estimate incorporates the impairments at Grimsby and Heiligenkreuz. Lenzing had reported EBIT of minus EUR 55.1 million for the first nine months of 2026, a figure that included non-cash writedowns of EUR 136.1 million.

Should investors sell immediately? Or is it worth buying Lenzing?

The unchanged rating shouldn't obscure the fact that Berenberg now values the stock lower. Nor does the cut reveal how much each of the two impairments contributed to it — the target applies to the share as a whole, not to any single site.

Capital Deployed vs. Carrying Values

For investors, the more instructive question is what Lenzing can earn on the capital it puts to work at each location. On November 12, the company said it would invest EUR 27 million in additional specialty fiber capacity at its Mobile, Alabama site, part of a broader EUR 50 million investment program for the nonwovens business. That outlay signals where Lenzing is committing capital; it says nothing on its own about the return that capital will generate.

An impairment works differently. It concerns money already sunk into a site, correcting a carrying value rather than reflecting a matching cash outflow. The Alabama expansion can't be set off against writedowns elsewhere — one is a decision about deploying capital, the other an adjustment to the valuation of existing assets.

Heiligenkreuz: Bids on the Table, Deadline at End-2026

At Heiligenkreuz, Lenzing is reviewing several non-binding purchase offers, per APA. By the end of 2026, the company intends to determine whether a viable sale can be reached — otherwise the plant will be shut at the end of the first quarter of 2027. That decision, not the size of the Alabama check, is what will ultimately test whether Lenzing's capital allocation creates value for shareholders.

Ad

Lenzing Stock: New Analysis - 21 November

Fresh Lenzing information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Lenzing analysis...

Disclaimer...
en | AT0000644505 | LENZINGS | boerse | 70541544 |